PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
97.89%
Net income growth above 1.5x MCHP's 1.85%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
0.24%
Less D&A growth vs. MCHP's 3.33%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-1011.11%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
79.25%
Well above MCHP's 78.29% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
94.23%
Inventory shrinking or stable vs. MCHP's 283.47%, indicating lean supply management. David Dodd would confirm no demand shortfall.
No Data
No Data available this quarter, please select a different quarter.
71.96%
Growth well above MCHP's 74.06%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
119.51%
Some yoy increase while MCHP is negative at -23.52%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
45.99%
Operating cash flow growth similar to MCHP's 50.64%. Walter Schloss would see parallel improvements or market conditions in cash generation.
-51.98%
Negative yoy CapEx while MCHP is 70.32%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
8.58%
Purchases growth of 8.58% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
9.52%
Liquidation growth of 9.52% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
100.00%
We have some outflow growth while MCHP is negative at -100.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
128.85%
Investing outflow well above MCHP's 69.98%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-66.18%
Negative yoy issuance while MCHP is 60.82%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
93.00%
Buyback growth of 93.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.